Home | Prescribing Information | Patient Website
Get Ready For ReFissa
Your patients can visit our Consumer Web site to learn more about ReFissa.
ReFissa 0.05% is indicated for mitigation (palliation) of fine facial wrinkles, mottled hyperpigmentation and tactile roughness in patients who use a comprehensive skin care and sunlight avoidance program (including sunscreen). ReFissa does not eliminate wrinkles, repair sun damaged skin, reverse photo-aging or restore more youthful or younger skin. Do not use if the patient is taking drugs known to be photosensitizers, pregnant, attempting pregnancy, or nursing. ReFissa, early in treatment, may cause redness, itching, burning, stinging and peeling. If the degree of irritation warrants, patient should be advised to use less medication and decrease the frequency of application. If still significant, patient should be advised to discontinue use. Please see full Prescribing Information. ReFissa is a registered trademark of ZO® Skin Health, Inc. © 2017 ZO® Skin Health, Inc. All rights reserved.
ZO® Skin Health, Inc. | Privacy Statement | Patient Product Information | Full Prescribing Information | Clinical Trial Information
| About ReFissa | Patient Experience | Patient Education & Resources
SM 1321-28 REV00